Lista de obras -

Buruli ulcer

artículo científico publicado en 2005

Buruli ulcer disease: prospects for a vaccine

artículo científico publicado en 2009

Buruli ulcer: emerging from obscurity.

artículo científico publicado en 2006

Clearance of viable Mycobacterium ulcerans from Buruli ulcer lesions during antibiotic treatment as determined by combined 16S rRNA reverse transcriptase /IS 2404 qPCR assay.

artículo científico publicado en 2017

Clinical and Bacteriological Efficacy of Rifampin-Streptomycin Combination for Two Weeks followed by Rifampin and Clarithromycin for Six Weeks for Treatment of Mycobacterium ulcerans Disease.

artículo científico publicado en 2014

Clinical and bacteriological efficacy of rifampin-streptomycin combination for two weeks followed by rifampin and clarithromycin for six weeks for treatment of Mycobacterium ulcerans disease.

artículo científico publicado en 2013

Combined inflammatory and metabolic defects reflected by reduced serum protein levels in patients with Buruli ulcer disease

artículo científico publicado en 2014

Effects of hydroxychloroquine on immune activation and disease progression among HIV-infected patients not receiving antiretroviral therapy: a randomized controlled trial

artículo científico publicado en 2012

Genetic diversity of PCR-positive, culture-negative and culture-positive Mycobacterium ulcerans isolated from Buruli ulcer patients in Ghana

artículo científico publicado en 2014

High prevalence of multidrug-resistant tuberculosis among patients with rifampicin resistance using GeneXpert Mycobacterium tuberculosis/rifampicin in Ghana

artículo científico publicado en 2016

IFN-γ and IL-5 whole blood response directed against mycolactone polyketide synthase domains in patients with infection

scientific article published on 31 July 2018

Immunosuppressive signature of cutaneous Mycobacterium ulcerans infection in the peripheral blood of patients with buruli ulcer disease

artículo científico publicado en 2009

Infection with Mansonella perstans Nematodes in Buruli Ulcer Patients, Ghana

artículo científico publicado en 2014

Metabolomic profiles delineate mycolactone signature in Buruli ulcer disease.

artículo científico publicado en 2015

Microbiological, histological, immunological, and toxin response to antibiotic treatment in the mouse model of Mycobacterium ulcerans disease

artículo científico publicado en 2013

Mycobacterium ulcerans Disease: Buruli Ulcer

Mycobacterium ulcerans infection (Buruli or Bairnsdale ulcer): challenges in developing management strategies

artículo científico publicado en 2007

Mycolactone diffuses into the peripheral blood of Buruli ulcer patients--implications for diagnosis and disease monitoring

artículo científico publicado en 2011

Neglected tropical diseases

artículo científico publicado en 2010

Oral treatment for patients with Buruli ulcer co-infected with HIV: think twice

artículo científico publicado en 2014

Paradoxical reactions in Buruli ulcer after initiation of antibiotic therapy: Relationship to bacterial load

artículo científico publicado en 2019

Rapid detection of Mycobacterium ulcerans with isothermal recombinase polymerase amplification assay

artículo científico publicado en 2019

Recent advances: role of mycolactone in the pathogenesis and monitoring of Mycobacterium ulcerans infection/Buruli ulcer disease.

artículo científico publicado en 2016

Reply to "compliance with antimicrobial therapy for buruli ulcer".

artículo científico publicado en 2014

Rifampicin and clarithromycin (extended release) versus rifampicin and streptomycin for limited Buruli ulcer lesions: a randomised, open-label, non-inferiority phase 3 trial

artículo científico publicado en 2020

Simple, Rapid Mycobacterium ulcerans Disease Diagnosis from Clinical Samples by Fluorescence of Mycolactone on Thin Layer Chromatography

artículo científico publicado en 2015

Treatment of tuberculosis in HIV-infected individuals

article

Lista de obras de

Buruli ulcer

Buruli ulcer disease: prospects for a vaccine

Buruli ulcer: emerging from obscurity.

Clearance of viable Mycobacterium ulcerans from Buruli ulcer lesions during antibiotic treatment as determined by combined 16S rRNA reverse transcriptase /IS 2404 qPCR assay.

Clinical and Bacteriological Efficacy of Rifampin-Streptomycin Combination for Two Weeks followed by Rifampin and Clarithromycin for Six Weeks for Treatment of Mycobacterium ulcerans Disease.

Clinical and bacteriological efficacy of rifampin-streptomycin combination for two weeks followed by rifampin and clarithromycin for six weeks for treatment of Mycobacterium ulcerans disease.

Combined inflammatory and metabolic defects reflected by reduced serum protein levels in patients with Buruli ulcer disease

Effects of hydroxychloroquine on immune activation and disease progression among HIV-infected patients not receiving antiretroviral therapy: a randomized controlled trial

Genetic diversity of PCR-positive, culture-negative and culture-positive Mycobacterium ulcerans isolated from Buruli ulcer patients in Ghana

High prevalence of multidrug-resistant tuberculosis among patients with rifampicin resistance using GeneXpert Mycobacterium tuberculosis/rifampicin in Ghana

IFN-γ and IL-5 whole blood response directed against mycolactone polyketide synthase domains in patients with infection

Immunosuppressive signature of cutaneous Mycobacterium ulcerans infection in the peripheral blood of patients with buruli ulcer disease

Infection with Mansonella perstans Nematodes in Buruli Ulcer Patients, Ghana

Metabolomic profiles delineate mycolactone signature in Buruli ulcer disease.

Microbiological, histological, immunological, and toxin response to antibiotic treatment in the mouse model of Mycobacterium ulcerans disease

Mycobacterium ulcerans Disease: Buruli Ulcer

Mycobacterium ulcerans infection (Buruli or Bairnsdale ulcer): challenges in developing management strategies

Mycolactone diffuses into the peripheral blood of Buruli ulcer patients--implications for diagnosis and disease monitoring

Neglected tropical diseases

Oral treatment for patients with Buruli ulcer co-infected with HIV: think twice

Paradoxical reactions in Buruli ulcer after initiation of antibiotic therapy: Relationship to bacterial load

Rapid detection of Mycobacterium ulcerans with isothermal recombinase polymerase amplification assay

Recent advances: role of mycolactone in the pathogenesis and monitoring of Mycobacterium ulcerans infection/Buruli ulcer disease.

Reply to "compliance with antimicrobial therapy for buruli ulcer".

Rifampicin and clarithromycin (extended release) versus rifampicin and streptomycin for limited Buruli ulcer lesions: a randomised, open-label, non-inferiority phase 3 trial

Simple, Rapid Mycobacterium ulcerans Disease Diagnosis from Clinical Samples by Fluorescence of Mycolactone on Thin Layer Chromatography

Treatment of tuberculosis in HIV-infected individuals